Evaluate the Effect of Vimseltinib on Organic Cation Transporter 2 (OCT2)

Clinical trial NCT07158411 · COMPLETED

Trial details

NCT number: NCT07158411
Sponsor: Deciphera Pharmaceuticals, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-11-20
Primary completion: 2026-01-30
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.